It is possible that PPARα may inhibit the activity of a degenerin channel, possibly ASIC2 or a hybrid ENaC–ASIC channel, that has yet to be identified in hepatic cells, and disruption of this regulatory system in the liver may be a driver for metabolic syndrome development (55). Here, ASIC1 is linked to metabolic syndrome.